rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1998-7-22
|
pubmed:abstractText |
The aim of the study was to evaluate the effects on systemic and coronary haemodynamics and myocardial substrate utilization of a new calcium sensitizer, levosimendan, after coronary artery bypass grafting.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0195-668X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
660-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9597417-Adult,
pubmed-meshheading:9597417-Aged,
pubmed-meshheading:9597417-Analysis of Variance,
pubmed-meshheading:9597417-Cardiac Output,
pubmed-meshheading:9597417-Cardiotonic Agents,
pubmed-meshheading:9597417-Coronary Artery Bypass,
pubmed-meshheading:9597417-Coronary Circulation,
pubmed-meshheading:9597417-Coronary Disease,
pubmed-meshheading:9597417-Dose-Response Relationship, Drug,
pubmed-meshheading:9597417-Double-Blind Method,
pubmed-meshheading:9597417-Electrocardiography,
pubmed-meshheading:9597417-Female,
pubmed-meshheading:9597417-Hemodynamics,
pubmed-meshheading:9597417-Humans,
pubmed-meshheading:9597417-Hydrazones,
pubmed-meshheading:9597417-Male,
pubmed-meshheading:9597417-Middle Aged,
pubmed-meshheading:9597417-Myocardium,
pubmed-meshheading:9597417-Oxygen Consumption,
pubmed-meshheading:9597417-Postoperative Care,
pubmed-meshheading:9597417-Postoperative Period,
pubmed-meshheading:9597417-Pyridazines,
pubmed-meshheading:9597417-Stroke Volume,
pubmed-meshheading:9597417-Treatment Outcome,
pubmed-meshheading:9597417-Vascular Resistance
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.
|
pubmed:affiliation |
Department of Medicine, Helsinki University Central Hospital, Finland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|